Intended for healthcare professionals

  1. Research
  2. Estimating treatment...
  3. Estimating treatment effects for individual patients based on the results of randomised clinical trials
CCBYNC Open access
Research

Estimating treatment effects for individual patients based on the results of randomised clinical trials

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5888 (Published 03 October 2011) Cite this as: BMJ 2011;343:d5888

Data supplement

  • Web Extra

    Extra material supplied by the author

    Files in this Data Supplement:

    • Data Supplement - Appendix 1: development of optimal fit model
    • Data Supplement - Appendix 2: example calculation of net benefit assessment method
    • Data Supplement - Appendix 3: application of treatment effect prediction methods to other datasets

Related articles

See more

Cited by...

  • Cardiovascular risk prediction tools made relevant for GPs and patients
  • Predictive approaches to heterogeneous treatment effects: a systematic review
  • Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
  • Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes
  • Treatment options in idiopathic subglottic stenosis: protocol for a prospective international multicentre pragmatic trial
  • Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
  • Development and validation of clinical prediction models for mortality, functional outcome and cognitive impairment after stroke: a study protocol
  • Response by Kaasenbrood et al to Letter Regarding Article, "Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population"
  • Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
  • Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis
  • Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study
  • How to translate clinical trial results into gain in healthy life expectancy for individual patients
  • Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
  • Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
  • Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement
  • Predicting the Effects of Blood Pressure-Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus: Results From Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation
  • Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
  • Using Internally Developed Risk Models to Assess Heterogeneity in Treatment Effects in Clinical Trials
  • A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials
  • High-Dose Statin Therapy in Patients With Stable Coronary Artery Disease: Treating the Right Patients Based on Individualized Prediction of Treatment Effect
Back to top